34633088	Dual-target inhibitors of bromodomain and extra-terminal proteins in cancer: A review from medicinal chemistry perspectives.	2021 Oct 11	Medicinal research reviews
34548613	Bromodomain proteins: protectors against endogenous DNA damage and facilitators of genome integrity.	2021 Sep	Experimental & molecular medicine
34540687	Anticancer Effects of I-BET151, an Inhibitor of Bromodomain and Extra-Terminal Domain Proteins.	2021	Frontiers in oncology
34520583	Emerging roles of bromodomain protein 4 in regulation of stem cell identity.	2021 Sep 14	Stem cells (Dayton, Ohio)
34438075	Dual-target inhibitors of bromodomain-containing protein 4 (BRD4) in cancer therapy: Current situation and future directions.	2021 Aug 23	Drug discovery today
34386523	Multiple Roles of Brd4 in the Infectious Cycle of Human Papillomaviruses.	2021	Frontiers in molecular biosciences
34362532	[Research Advances in the Mechanisms of BRD4 and Its Inhibitors in Hematologic Malignancies--Review].	2021 Aug	Zhongguo shi yan xue ye xue za zhi
34336926	Regulation of Carbohydrate-Responsive Metabolic Genes by Histone Acetylation and the Acetylated Histone Reader BRD4 in the Gene Body Region.	2021	Frontiers in molecular biosciences
34298819	Functional Roles of Bromodomain Proteins in Cancer.	2021 Jul 19	Cancers
33851008	BRD4: An emerging prospective therapeutic target in glioma.	2021 Jun 25	Molecular therapy oncolytics
33706239	Opportunity knocks for uncovering the new function of an understudied nucleosome remodeling complex member, the bromodomain PHD finger transcription factor, BPTF.	2021 Aug	Current opinion in chemical biology
33616410	Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development.	2021 Mar 11	Journal of medicinal chemistry
33601323	Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE.	2021 Mar	European journal of cancer (Oxford, England : 1990)
33574760	Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials.	2020	Frontiers in pharmacology
33452461	Supercharging BRD4 with NUT in carcinoma.	2021 Feb	Oncogene
33413475	Modulation of BRD4 in HIV epigenetic regulation: implications for finding an HIV cure.	2021 Jan 7	Retrovirology
33345363	Bromodomain-containing protein 4 and its role in cardiovascular diseases.	2021 Jul	Journal of cellular physiology
32926459	Inhibitors of bromodomain and extra-terminal proteins for treating multiple human diseases.	2021 Jan	Medicinal research reviews
32893690	Proteolysis-targeting chimeras mediate the degradation of bromodomain and extra-terminal domain proteins.	2020 Sep	Future medicinal chemistry
32714883	Bromodomain Inhibitors as Therapeutics for Herpesvirus-Related Disease: All BETs Are Off?	2020	Frontiers in cellular and infection microbiology
32693114	Targeting BET bromodomain proteins in cancer: The example of lymphomas.	2020 Nov	Pharmacology & therapeutics
32520674	Dual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer.	2021	Current medicinal chemistry
32502863	Novel strategies targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery.	2020 Aug 15	European journal of medicinal chemistry
32409773	The therapeutic potential of BRD4 in cardiovascular disease.	2020 Oct	Hypertension research : official journal of the Japanese Society of Hypertension
32331282	RSV Reprograms the CDK9•BRD4 Chromatin Remodeling Complex to Couple Innate Inflammation to Airway Remodeling.	2020 Apr 22	Viruses
32191554	Bromodomain AAA+ ATPases get into shape.	2020 Dec	Nucleus (Austin, Tex.)
31931101	Make your best BET: The emerging role of BET inhibitor treatment in malignant tumors.	2020 Apr	Pharmacology & therapeutics
31870185	Developments in drug design strategies for bromodomain protein inhibitors to target <i>Plasmodium falciparum</i> parasites.	2020 Apr	Expert opinion on drug discovery
31815566	A patent review of BRD4 inhibitors (2013-2019).	2020 Jan	Expert opinion on therapeutic patents
31780938	Bromodomain and Extraterminal Proteins as Novel Epigenetic Targets for Renal Diseases.	2019	Frontiers in pharmacology
31733396	Validation of the epigenetic reader bromodomain-containing protein 4 (BRD4) as a therapeutic target for treatment of airway remodeling.	2020 Jan	Drug discovery today
31726225	Emerging tools to investigate bromodomain functions.	2020 Dec 1	Methods (San Diego, Calif.)
31582847	Bromodomain biology and drug discovery.	2019 Oct	Nature structural & molecular biology
31582844	Targeting non-bromodomain chromatin readers.	2019 Oct	Nature structural & molecular biology
31581671	Pharmacological Targeting of BET Bromodomain Proteins in Acute Myeloid Leukemia and Malignant Lymphomas: From Molecular Characterization to Clinical Applications.	2019 Oct 2	Cancers
31364510	Recent Advances in the Development of CBP/p300 Bromodomain Inhibitors.	2020	Current medicinal chemistry
31215391	Bromodomain-Containing Protein 4: A Druggable Target.	2019	Current drug targets
31200858	Small-molecule PROTAC degraders of the Bromodomain and Extra Terminal (BET) proteins - A review.	2019 Apr	Drug discovery today. Technologies
31116107	Bromodomain and Extra-Terminal domain inhibitors for lymphoid malignancies.	2019 Jul	Current opinion in hematology
30906568	Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy.	2019 Mar	Future science OA
30832981	Emerging roles of and therapeutic strategies targeting BRD4 in cancer.	2019 Mar	Cellular immunology
30693439	How Might Bromodomain and Extra-Terminal (BET) Inhibitors Operate in Cardiovascular Disease?	2019 Apr	American journal of cardiovascular drugs : drugs, devices, and other interventions
30633431	Chemical Epigenetics: The Impact of Chemical and Chemical Biology Techniques on Bromodomain Target Validation.	2019 Dec 9	Angewandte Chemie (International ed. in English)
30624862	Advancements in the Development of non-BET Bromodomain Chemical Probes.	2019 Feb 19	ChemMedChem
30564450	Bromodomain protein inhibition: a novel therapeutic strategy in rheumatic diseases.	2018	RMD open
30542529	Targeting Brd4 for cancer therapy: inhibitors and degraders.	2018 Nov 1	MedChemComm
30466442	BRD4 and Cancer: going beyond transcriptional regulation.	2018 Nov 22	Molecular cancer
30414936	From bench to bedside, via desktop. Recent advances in the application of cutting-edge in silico tools in the research of drugs targeting bromodomain modules.	2019 Jan	Biochemical pharmacology
30289209	Bromodomain Drug Discovery - the Past, the Present, and the Future.	2018 Dec	Chemical record (New York, N.Y.)
30230450	[P-TEFb and Brd4: actors of the transcription pause release as therapeutical targets].	2018 Aug-Sep	Medecine sciences : M/S
30067623	Bromodomain inhibitors: what does the future hold?	2018 Jul	Clinical advances in hematology & oncology : H&O
29620420	Research progress of selective small molecule bromodomain-containing protein 9 inhibitors.	2018 Apr 1	Future medicinal chemistry
29415456	BET Family Protein BRD4: An Emerging Actor in NFκB Signaling in Inflammation and Cancer.	2018 Feb 6	Biomedicines
29233295	Novel approaches to targeting BRD4.	2017 Jun	Drug discovery today. Technologies
29154989	Targeting bromodomain and extraterminal proteins in breast cancer.	2018 Mar	Pharmacological research
28943305	Targeting the cancer epigenome: synergistic therapy with bromodomain inhibitors.	2018 Jan	Drug discovery today
28847823	Bromodomain proteins: repairing DNA damage within chromatin.	2017 Oct 5	Philosophical transactions of the Royal Society of London. Series B, Biological sciences
28721198	BRD4 inhibition for the treatment of pathological organ fibrosis.	2017	F1000Research
28714212	Fragment-Based Drug Discovery in the Bromodomain and Extra-Terminal Domain Family.	2017 Aug	Archiv der Pharmazie
28695816	Research Advances in the Role of Bromodomain-containing Protein 4 in Epithelial-mesenchymal Transition in Asthma.	2017 Jun 20	Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
28624514	Bromodomain-containing proteins in prostate cancer.	2018 Feb 15	Molecular and cellular endocrinology
28580303	The Role of Bromodomain Testis-Specific Factor, BRDT, in Cancer: A Biomarker and A Possible Therapeutic Target.	2017 Spring	Cell journal
28569271	Heart failure: BRD4 inhibition slows HF progression.	2017 Jul	Nature reviews. Cardiology
28541716	Investigational BET bromodomain protein inhibitors in early stage clinical trials for acute myelogenous leukemia (AML).	2017 Jul	Expert opinion on investigational drugs
28500727	Biological function and histone recognition of family IV bromodomain-containing proteins.	2018 Mar	Journal of cellular physiology
28213432	Targeting Cancer Cells with BET Bromodomain Inhibitors.	2017 Jul 5	Cold Spring Harbor perspectives in medicine
28195723	Drug Discovery Targeting Bromodomain-Containing Protein 4.	2017 Jun 8	Journal of medicinal chemistry
28174254	The Essential Transcriptional Function of BRD4 in Acute Myeloid Leukemia.	2016	Cold Spring Harbor symposia on quantitative biology
28062533	BET Bromodomain Proteins as Cancer Therapeutic Targets.	2016	Cold Spring Harbor symposia on quantitative biology
28053347	Functions of bromodomain-containing proteins and their roles in homeostasis and cancer.	2017 Apr	Nature reviews. Molecular cell biology
